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Background. Our objective is to describe a program to
improve awareness and management of hypertension, renal
disease, and diabetes in 3 remote Australian Aboriginal com-
munities.
Methods. The program espouses that regular integrated
checks for chronic disease and their risk factors are essential
elements of regular adult health care. Programs should be run
by local health workers, following algorithms for testing and
treatment, with backup, usually from a distance, from nurse
coordinators. Constant evaluation is essential to develop com-
munity health profiles and adapt program structure.
Results. Participation ranged from 65% to 100% of adults.
Forty-one percent of women and 72% of men were current
smokers. Body weight varied markedly by community. Al-
though excessive in all, rates of chronic diseases also differed
markedly among communities. Rates increased with age, but
the greatest numbers of people with morbidities were middle
age and young adults. Multiple morbidities were common by
middle age. Hypertension and renal disease were early features,
whereas diabetes was a variable and later manifestation of this
integrated chronic disease syndrome. Adherence to testing and
treatment protocols improved markedly over time. Substantial
numbers of new diagnoses were made. Blood pressure improved
in people in whom antihypertensive agents were started or in-
creased. Components of a systematic activity plan became more
clearly defined with time. Treatment of people in the commu-
nity with the greatest disease burden posed a large additional
workload. Lack of health workers and absenteeism were major
impediments to productivity.
Conclusion. We cannot generalize about body habitus, and
chronic disease rates among Aboriginal adults. Pilot data are
needed to plan resources based on the chronic disease bur-
den in each community. Systematic screening is useful in iden-
tifying high-risk individuals, most at an early treatable stage.
Community-based health profiles provide critical information
for the development of rational health policy and needs-based
health services.
Key words: Australian Aborigines, prevention program, cardiovascular
and renal protection, chronic diseases, outreach services, community-
based.
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An epidemic of renal and related chronic diseases has
appeared in remote Australian Aboriginal communities
since the early 1980s. Death rates are greatly elevated
[1, 2], whereas incidence rates of treated end-stage re-
nal disease (ESRD) in remote areas are up to 1500 per
million, and in some individual communities ≥3000 per
million [3, 4]. The estimated 1996/1997 costs of maintain-
ing one Aboriginal person on dialysis for a year was Aus
$112,000; $71,000 for treatments and $41,000 for intercur-
rent hospitalizations [5].
Renal disease is marked by pathologic albuminuria.
Rates and intensities are strongly age related, with half of
all adults in some groups affected. In a community-wide
screening program in one high-risk group, we showed that
albuminuria is multideterminant; increasing body weight
or fat, syndrome X features, carotid intimal media thick-
ness, lower birth weights, markers of inflammation, skin
and other infections, remote episodes of poststreptococ-
cal glomerulonephritis, heavy drinking, grand multipar-
ity, and a family history all significantly correlated with
albuminuria after accounting for age [6–9]. Albuminuria
predicts all risk for renal failure over the intermediate
term; it also powerfully predicts nonrenal deaths, marking
most or all of the risk for excess mortality in this popula-
tion [10, 11]. Coronial autopsies indicate fewer and larger
nephrons in Aborigines [12], and renal biopsies in peo-
ple with clinical renal disease, while containing the usual
spectrum of diagnoses, commonly show marked glomeru-
lomegaly and variable glomerulosclerosis [13–15].
Primary prevention depends on a multitude of changes,
related as much to socioeconomic advancement as to
changes in health care. Even if successfully implemented,
they will take time to moderate disease incidence. The
modification of existing disease, however, is entirely fea-
sible. In the same high-risk community, we demonstrated
the powerful benefit of systematic management with
angiotensin-converting enzyme inhibition in reducing re-
nal failure and nonrenal natural deaths, with huge es-
timated cost savings [16–19]. Among people with overt
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Table 1. Principles of the chronic disease outreach program for remote Aboriginal communities
Regular testing of all adults for chronic disease and risk factors, and treatment for those in need, are essential components of adult health care.
The program is run by health workers who follow algorithms for testing and treatment.
Use of limited number of medicines to maximize familiarity.
Nurse coordinators provide backup, from a distance, so that one serves several communities/regions.
Doctors provide backup for problematic cases and treatment questions, so that one can serve an entire region.
Maximum use of telephone, fax, e-mail, and web for communications.
Computerized database.
Constant evaluation for individual profiles, community profiles, processes, and outcomes.
Table 2. Regular checkup: Chronic disease outreach program
Minimal elements
Chart review: Existing diagnoses, complications, parity,
contraception, medicines, and so forth
History: smoking, drinking, drugs, existing diagnoses, menstruating?
Weight, height (once)
Blood pressure
Skin examination for sores, scabies, fungal infections
Urine dipstick for protein, blood, nitrites leukocytes
Capillary fingerstick for hemoglobin
Capillary fingerstick for random glucose
Some common additional tests according to algorithms
Repeat urine if apparently contaminated
Urine culture if apparently infected
Urine ACR if dipstick 1+; if diabetic, hypertensive, or history of
proteinuria
Fasting glucose if random glucose suspicious
HbA1c if diabetic
Full blood count if anemic
Serum creatinine if overt albuminuria (ACR 34+)
Electrolytes if considering ACEI treatment
Lipids sometimes
In addition
Involve the participant
Maximize on-site testing
Immediate feedback and education
Personalize health goals
Start treatment on first visit if needed/possible
Abbreviations are: ACR, albumin:creatine ratio; HbA1c, hemoglobin A1c;
ACEI, angiotensin-converting enzyme inhibitor.
albuminuria, analyzed on an intention-to-treat basis, one
terminal event was avoided for every 9.5 people enrolled
in the program for a mean of 3.4 years [17].
THE CHRONIC DISEASE OUTREACH
PROGRAM
Building on this experience and after an early attempt
to formulate some guidelines and recommendations [19,
20], we designed the Aboriginal Chronic Disease Out-
reach Program to help additional remote communities
improve their awareness and management of chronic
disease [21–24]. Many remote communities are small,
sometimes physically inaccessible, have a high turnover
of non-Aboriginal personnel, and do not have a resident
doctor.
The elements of the program are summarized in
Table 1. In our program, the database is web based, al-
lowing review, interactive dialogue, and multiparty con-
sultation from a distance, and direct upload of laboratory
data. The components of testing are shown in Table 2.
We commonly add a brief examination of heart and lungs
and peripheral pulses. Some of the emphases reflect lo-
cal problems (skin infections/infestations), intestinal par-
asites causing anemia, and so forth, and might not be
important in other settings. Other elements can be added
to optimize use of a regular encounter, such as immuniza-
tions, sexually transmitted disease checks, cancer checks,
etc.
Findings
The program has been extended to three additional
remote communities in the Northern Territory and to
two community-controlled Aboriginal medical services
in Western Australia. Two thirds to 100% of adults have
been tested at least once in the Northern Territory com-
munities. The results are summarized as follows [24].
Forty-one percent of women and 72% of men were smok-
ers. Most men were current users of alcohol, but most
women were not. Marijuana use among young people was
usual where histories were considered reliable. All pa-
rameters of body weight differed by community, as shown
for weight in Figure 1. Mean body mass index (BMI) var-
ied from 21 kg/m2 in community A to 27 kg/m2 in com-
munity C (P < 0.001). Waist circumference was relatively
more increased than BMI, particularly in women. Even in
community A, where 74% of women were of low or ideal
BMI, 77% were “overweight” or “obese” by the stan-
dard waist measurements of >82 cm for non-Aboriginal
women [25]. Rates of hypertension, proteinuria, and di-
abetes were strongly correlated with increasing age in all
communities, demonstrated for community C in Figure 2.
However, because of the youthful age distribution of this
population, the largest number of people with morbidi-
ties was in young and middle-aged adults, shown in Figure
3. Average rates of these morbidities, although excessive
in all, differed at least 2-fold among these communities,
as shown in Figure 4. Proteinuria and hypertension were
early features of the health profile, whereas diabetes was
a later and more variable element, as Figure 2 also shows.
Coexistence of multiple morbidities was usual by middle
age and inevitable in older people. Figure 5 shows such in-
tegration in community B, which had intermediate rates
of morbidities.
Morbidities were also strongly correlated with mea-
sures of body weight, of which waist was usually the most
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Fig. 1. Weight (kilogram) by age group and community.
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Fig. 2. Percentage of people with morbidities by age in community C,
adjusted for sex.
80
70
60
50
40
30
20
10
0
N
um
be
r o
f p
er
so
ns
<25 25-39 40-54 >55
Age, years
Hypertension
Renal disease
Diabetes
Fig. 3. Number of persons with morbidities by age in community C.
powerful and with birth weight (inversely, and for women
only). Women had more renal disease and diabetes than
men, whereas men had higher rates of hypertension. Al-
cohol use was associated with an almost doubling of rates
of hypertension in women.
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Fig. 4. Percentage of people with morbidities by community, adjusted
for age and sex.
Program activities
The workload gradually defined itself in the follow-
ing categories: (1) regular screening, which can be pre-
dicted and scheduled, according to the population base;
(2) follow-up of those with equivocal or abnormal re-
sults, which can happen in the same encounter, or one
additional encounter, depending on the disease burden;
(3) initiation, upward titration, and monitoring of treat-
ment. A multiplication effect then follows, with the total
workload depending on the burden of disease, complex-
ity of an individual’s problems, and his or her response
to intervention; in community C, the treatment activities,
properly conducted, would have overwhelmed the pro-
gram, even if work attendance had been regular; (4) catch
up, recording, restocking; (5) clinic and staff meetings; (6)
community and individual education; (7) education and
training updates, and so forth.
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Fig. 5. Overlapping and coexisting morbidi-
ties by age group, demonstrated in community
B.
After assessing the relevant needs, it is wise to allo-
cate specific blocks of time each week or month to these
activities, so that none gets shortchanged.
Staffing
The fundamental difficultly in the program was short-
age of local health workers and frequent absenteeism
of those employed. These issues impact on health care
more broadly. The causes are complex and deep-seated,
but improved incentives for health workers, proper pay
scales, empowerment, respect, and good backup are all
needed.
Processes
Adherence to protocols increased with time, reflected
in much-improved rates of repeat readings in people
with high blood pressures (BPs), of hemoglobin A1c
(HbA1c) measurements in diabetics, and of urine albu-
min:creatinine ratios in diabetics, people with hyperten-
sion, and in people with dipstick-positive urine tests. This
adherence varied by gender of participants according to
the gender of the health workers and nurse coordina-
tors, in an environment where women’s and men’s care
streams are usually separate.
New diagnoses
Among 1070 people, 57 new diagnoses of hypertension
were made, with 196 probable new cases of renal disease
and 48 new cases of diabetes. Although some of these
cases might have been truly “missed” in the past, this
probably reflects the time-related incidence of new dis-
ease in people since they were last checked and, for renal
disease, expanded testing. If some proportion of these
people receive intensified surveillance and appropriate
treatment, this substantial new ascertainment should re-
sult in better outcomes.
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Fig. 6. Blood pressure trends in 104 people with BP ≥140/90 at base-
line, in whom antihypertensive treatment was started or intensified.
Clinical outcomes
Hypoglycemic treatment was started or intensified in
63% of patients with diabetes, although there was no net
improvement in HbA1c among repeat levels recorded
(8.0% vs. 8.1%). Angiotensin-converting enzyme in-
hibitor (ACEI) treatment was started or intensified in
60% of patients with diabetes and in 12% of those with-
out diabetes, although dose was not optimally titrated in
some. At the end of the program, 82% of patients with
diabetes and 98% of diabetics with albuminuria had been
prescribed ACEI. There was a significant fall in BP in 174
people in whom ACEI therapy was started or intensified
and who had a repeat BP reading, and a sharper reduc-
tion in those who were hypertensive at baseline examina-
tion, as shown in Figure 6. This response was essentially
the same for patients with diabetes and those without
diabetes. The magnitude of the BP responses varied by
community and gender, according to the gender of the lo-
cal health workers and therefore the people with whom
he or she could most comfortably relate. In community
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C, where the health worker and nurse coordinator were
both female, mean systolic blood pressure (SBP) fell by
20 mm Hg, and mean diastolic blood pressure fell by 14.3
mm Hg in women with baseline BP ≥140/90 in whom
treatment changes were made (P < 0.001 for both).
CHANGES IN CONCEPTUAL FRAMEWORKS
Generalizations cannot be made about body habi-
tus or chronic disease rates, even in remote communi-
ties in the same (albeit very large) geographic region.
Stereotypes like “excessive drinking,” or “widespread
obesity” are also inappropriate. The data show that
morbidities are best considered elements of a single
vascular/renal/metabolic syndrome, rather than separate
entities. Diabetes is a late variable and probably terminal
feature of that syndrome, rather than the central cause
of proteinuria and higher BPs. This informs us about
pathophysiology and should focus attention on interven-
tions well upstream from established diabetes. Although
we do not have an explanation of the full magnitude of
the excess disease burden, it is clear that greater body
size or fat exacerbates risk, that alcohol contributes
to risk, and that more robust birth weights should re-
duce risk. It is also certain that smoking at these lev-
els is seriously harmful and a prime target for aggressive
intervention.
People who received ACEI treatment had a good BP
response, although poor staffing levels and absenteeism
meant that medicines were often not optimally titrated.
Nonetheless, data from the Asia Pacific region, which pre-
dict a 56% reduction in stroke and a 46% reduction in
ischemic heart disease in people <60 years of age for ev-
ery 10 mm Hg reduction in SBP [26], suggest that BP
reductions achieved here, if sustained, should result in
major lowering of mortality from stroke and ischemic
heart disease, as well as reduced complications and hospi-
talizations from chronic disease more broadly. They also
predict major reductions in the development and rate of
progression of renal disease. With 31% of the population
taking ACEI at the end of the program, there is also the
intriguing possibility that the incidence of type 2 diabetes
will be reduced in those who are currently not diabetic,
based on an incidental but consistent finding in several
recent large randomized trials targeting cardiovascular
endpoints (HOPE, ALLHAT, EUROPA, ANBP2, and
PROGRESS).
SIGNIFICANCE FOR HEALTH SERVICES
PLANNING AND POLICY
Chronic disease awareness has increased dramatically
across Australia in the last 10 years, stimulated in part
by the crisis in indigenous health. Major nongovern-
ment chronic disease organizations, the Australian Kid-
ney Foundation, the National Heart Foundation, the
Stroke Foundation, and Diabetes Australia, are collab-
orating to integrate population-based policies under the
“Chronic Disease Alliance,” and are taking an increasing
interest in indigenous health. Most standard care guide-
lines for Aboriginal adults now include regular integrated
testing and treatment for chronic disease [27, 28], and
there are excellent information sources [29]. Although
resources for those services are quite inadequate, new
resourcing mechanisms are being evaluated by the fed-
eral government. These include a capitation payment for
primary health care and a new Medicare reimbursement
item for a biannual chronic disease check for indigenous
people 15 years of age and older. Reimbursements still
primarily reward services by doctors rather than health
workers, or depend on elaborate “case conferencing” sce-
narios, but this might change as the efficiencies of a health
worker-controlled program are recognized. Access to
medications through the Australian Pharmaceutical Ben-
efits Scheme has been facilitated, and reimbursement for
some point-of-care diagnostic tests, such as HbA1c levels
and urine microalbumin measurement, has been intro-
duced. The Commonwealth Government has undertaken
to supply the Ferret computerized information technol-
ogy health care system to the communities or services it
supports, although more attention is needed for startup
and ongoing training in its use. Needed now are stan-
dard approaches to services and funding across states,
regions, and communities, indexing to local burdens of
disease, and robust systems for accountability in expen-
ditures, practice, and outcomes.
Community profiles, like those described here, provide
much information for needs-based health services plan-
ning [24, 30, 31]. The increase in disease rates with age
means that repeated testing needs to occur throughout
life to detect treatable conditions as they develop. They
can probably also suggest the optimum frequency of such
testing, which would avoid excessive use of resources on
the one hand, but pick up most newly appearing morbidi-
ties reasonably early on the other. The age-related pat-
tern also allows predictions of future burdens of disease
as the population ages. The predominance of young and
middle aged people among those with morbidities antici-
pates many years of treatment and intensified follow-up,
if they are to have a reasonable life expectancy. The dif-
ferent rates of morbidities among communities mean that
pilot data are needed to rationally plan resources to deal
with chronic disease in individual sites; a simple review of
existing clinic records might serve this purpose. The co-
existence of morbidities justifies integrated, rather than
disease-specific, chronic disease screening and suggests
that most people will be on multiple drugs by middle age.
It also implies that these conditions arise out of the same
environment and will be susceptible to the same menu of
primary and secondary prevention strategies. Finally, the
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coexistence of morbidities highlights the deficiencies and
inefficiencies of specialty-specific concepts and programs.
We are also evaluating the application of the Health
Benefit Group/Health Resources Group framework to
project chronic disease services’ needs and potential out-
comes [32–34]. Health Benefit Groups, originally applied
in the hospital setting, group people with a given condi-
tion according to their stage of disease. In the community
setting, entire populations at any one time can be grouped
in categories of no disease, high risk, asymptomatic dis-
ease, disease with symptoms, disease with complications
and, of course, for renal failure, irreversible organ failure.
Cells in the model can be populated with the numbers of
people in each category. Health Resources Groups rep-
resent “packages of care” for people at each stage: for
example, health promotion, health education and regular
screening for those at risk, treatment and surveillance for
complications in those with disease, specific management
of complications as they occur and, in the case of renal dis-
ease, planning for ESRD and, finally, ESRD treatment.
There is a sound evidence base for the clinical benefit
and, in some cases, cost savings, of interventions at each
of these stages for diabetes, hypertension, and renal
disease.
CONCLUSION
The anticipated improved outcomes and cost effective-
ness can be used for advocacy on humane as well as fis-
cal grounds. For diabetes, hypertension, and cardiovascu-
lar and renal disease, the potential savings from reduced
complications, hospitalizations, and delayed or avoided
dialysis, are impressive indeed. Allocation of a monetary
value to a year of death postponed for people in the prime
of life is an additional argument, although the more hu-
man side of this is better preservation within communities
of family stability, productivity, culture, and values.
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